Alps Advisors Inc Kezar Life Sciences, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.08 - $2.54 $434 - $1,021	402 Added 0.76%	53,625 $63,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $18,697 - $24,767	8,094 Added 17.94%	53,223 $130,000
Q1 2023 May 10, 2023	SELL	$3.13 - $7.31 $3,827 - $8,940	-1,223 Reduced 2.64%	45,129 $141,000
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $57,426 - $79,085	8,987 Added 24.05%	46,352 $326,000
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $12,208 - $16,426	1,528 Added 4.26%	37,365 $322,000
Q2 2022 Aug 11, 2022	SELL	$4.58 - $17.13 $67,193 - $251,314	-14,671 Reduced 29.05%	35,837 $296,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $78,314 - $116,707	-6,367 Reduced 11.19%	50,508 $839,000
Q4 2021 Feb 09, 2022	SELL	$7.44 - $16.72 $16,330 - $36,700	-2,195 Reduced 3.72%	56,875 $951,000
Q3 2021 Nov 15, 2021	SELL	$4.85 - $9.73 $20,709 - $41,547	-4,270 Reduced 6.74%	59,070 $510,000
Q2 2021 Aug 11, 2021	SELL	$4.93 - $6.46 $100,409 - $131,570	-20,367 Reduced 24.33%	63,340 $344,000
Q1 2021 May 07, 2021	BUY	$5.24 - $6.99 $4,647 - $6,200	887 Added 1.07%	83,707 $499,000
Q4 2020 Feb 03, 2021	BUY	$4.77 - $6.58 $395,051 - $544,955	82,820 New	82,820 $432,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $430M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.